Tert-Butylamine

Tert-Butylamine

SCHEMBL4699299

CC(C)(C)N.Cl.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEIDH1

The experimentally established mechanism targets of Tert-Butylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116217772-B Cycloolefin copolymer and preparation method thereof 中国科学院长春应用化学研究所 2024-05-28 CN disclosed
CN-114716599-B Olefin copolymer and preparation method and application thereof 中国石油化工股份有限公司 2024-02-13 CN disclosed
CN-113717304-B Ethylene copolymer and preparation method and application thereof 中国石油化工股份有限公司 2023-07-21 CN disclosed
CN-116217772-A Cycloolefin copolymer and preparation method thereof 中国科学院长春应用化学研究所 2023-06-06 CN disclosed
EP-4076492-A1 PCSK9 ANTAGONIST COMPOUNDS Merck Sharp & Dohme LLC (US) 2022-10-26 EP disclosed
CN-109311839-B Methylamine derivatives as lysyl oxidase inhibitors for the treatment of cancer 癌症研究协会皇家癌症医院 2021-11-02 CN disclosed
CN-109721613-B Macrocyclic amide compound containing quaternary ammonium ions, and pharmaceutical composition and application thereof 四川科伦博泰生物医药股份有限公司 2021-07-30 CN disclosed
WO-2021127460-A1 PCSK9 ANTAGONIST COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2021-06-24 WO disclosed
CN-106488918-B Triazolopyrimidone or triazolopyridinone derivatives and uses thereof ST制药株式会社 2020-02-28 CN disclosed
WO-2014124757-A1 PYRROLOTRIAZINE DERIVATIVES AS PI3K INHIBITORS ALMIRALL, S.A. (ES) 2014-08-21 WO disclosed
EP-1987037-A2 FUSED HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2008-11-05 EP disclosed
WO-2007097470-A2 FUSED NITROGEN- COMPRISING HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-08-30 WO disclosed
CN-1616496-A Catalyst component, catalyst and process for ethylenically unsaturated monomer polymerization MITSUI CHEMICALS INC (JP) 2005-05-18 CN disclosed
CN-1217685-A VULCANIZED MOLDING HAVING SURFACE DECORATIVE LAYER, PAINTED THERMOPLASTIC RESIN COMPOSITION AND PAINTED ELASTOMER COMPOSITION MITSUI CHEMICALS INC (JP) 1999-05-26 CN disclosed
CN-1171097-A Norbornene compound having chain polyene group and unsaturated ethylene copolymer prepared using the same MITSUI PETROCHEMICAL IND (JP) 1998-01-21 CN disclosed